288 related articles for article (PubMed ID: 23340313)
61. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
[TBL] [Abstract][Full Text] [Related]
62. Cryptococcus gattii virulence composite: candidate genes revealed by microarray analysis of high and less virulent Vancouver island outbreak strains.
Ngamskulrungroj P; Price J; Sorrell T; Perfect JR; Meyer W
PLoS One; 2011 Jan; 6(1):e16076. PubMed ID: 21249145
[TBL] [Abstract][Full Text] [Related]
63. In vivo assessment of differences in fungal cell density in cerebral cryptococcomas of mice infected with Cryptococcus neoformans or Cryptococcus gattii.
Vanherp L; Poelmans J; Govaerts K; Hillen A; Lagrou K; Vande Velde G; Himmelreich U
Microbes Infect; 2023; 25(6):105127. PubMed ID: 36940783
[TBL] [Abstract][Full Text] [Related]
64. Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.
He X; Lyons DM; Toffaletti DL; Wang F; Qiu Y; Davis MJ; Meister DL; Dayrit JK; Lee A; Osterholzer JJ; Perfect JR; Olszewski MA
Am J Pathol; 2012 Oct; 181(4):1356-66. PubMed ID: 22846723
[TBL] [Abstract][Full Text] [Related]
65. Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.
Silva VKA; May RC; Rodrigues ML
Med Mycol; 2020 Oct; 58(7):928-937. PubMed ID: 31915833
[TBL] [Abstract][Full Text] [Related]
66. Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe.
Cogliati M; Puccianti E; Montagna MT; De Donno A; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Trovato L; Dipineto L; Rickerts V; Akcaglar S; Mlinaric-Missoni E; Bertout S; Vencà ACF; Sampaio AC; Criseo G; Ranque S; Çerikçioğlu N; Marchese A; Vezzulli L; Ilkit M; Desnos-Ollivier M; Pasquale V; Polacheck I; Scopa A; Meyer W; Ferreira-Paim K; Hagen F; Boekhout T; Dromer F; Varma A; Kwon-Chung KJ; Inácio J; Colom MF
Environ Microbiol; 2017 Oct; 19(10):4318-4325. PubMed ID: 28892309
[TBL] [Abstract][Full Text] [Related]
67. Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii.
Ueno K; Kinjo Y; Okubo Y; Aki K; Urai M; Kaneko Y; Shimizu K; Wang DN; Okawara A; Nara T; Ohkouchi K; Mizuguchi Y; Kawamoto S; Kamei K; Ohno H; Niki Y; Shibuya K; Miyazaki Y
Infect Immun; 2015 Apr; 83(4):1577-86. PubMed ID: 25644007
[TBL] [Abstract][Full Text] [Related]
68. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
69. Clinical insights and epidemiology of central nervous system infection due to Cryptococcus neoformans/gattii species complexes: A prospective study from South India.
Lahiri S; Manjunath N; Bhat M; Hagen F; Bahubali VH; Palaniappan M; Maji S; Chandrashekar N
Med Mycol; 2020 Jul; 58(5):600-608. PubMed ID: 31578566
[TBL] [Abstract][Full Text] [Related]
70. The F-Box Protein Fbp1 Shapes the Immunogenic Potential of
Masso-Silva J; Espinosa V; Liu TB; Wang Y; Xue C; Rivera A
mBio; 2018 Jan; 9(1):. PubMed ID: 29317510
[No Abstract] [Full Text] [Related]
71. Immune modulation mediated by cryptococcal laccase promotes pulmonary growth and brain dissemination of virulent Cryptococcus neoformans in mice.
Qiu Y; Davis MJ; Dayrit JK; Hadd Z; Meister DL; Osterholzer JJ; Williamson PR; Olszewski MA
PLoS One; 2012; 7(10):e47853. PubMed ID: 23110112
[TBL] [Abstract][Full Text] [Related]
72. Resistance and Tolerance to Cryptococcal Infection: An Intricate Balance That Controls the Development of Disease.
Shourian M; Qureshi ST
Front Immunol; 2019; 10():66. PubMed ID: 30761136
[No Abstract] [Full Text] [Related]
73. Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing.
McTaggart L; Richardson SE; Seah C; Hoang L; Fothergill A; Zhang SX
J Clin Microbiol; 2011 Jul; 49(7):2522-7. PubMed ID: 21593254
[TBL] [Abstract][Full Text] [Related]
74. Cryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal species.
Schoffelen T; Illnait-Zaragozi MT; Joosten LA; Netea MG; Boekhout T; Meis JF; Sprong T
PLoS One; 2013; 8(1):e55579. PubMed ID: 23383232
[TBL] [Abstract][Full Text] [Related]
75. Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Alves GS; Freire AK; Bentes Ados S; Pinheiro JF; de Souza JV; Wanke B; Matsuura T; Jackisch-Matsuura AB
Mycoses; 2016 Aug; 59(8):509-15. PubMed ID: 27005969
[TBL] [Abstract][Full Text] [Related]
76. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
[TBL] [Abstract][Full Text] [Related]
77. Population diversity and virulence characteristics of Cryptococcus neoformans/C. gattii species complexes isolated during the pre-HIV-pandemic era.
Pharkjaksu S; Kwon-Chung KJ; Bennett JE; Ngamskulrungroj P
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008651. PubMed ID: 33017391
[TBL] [Abstract][Full Text] [Related]
78. Contribution of the myeloperoxidase-dependent oxidative system to host defence against Cryptococcus neoformans.
Aratani Y; Kura F; Watanabe H; Akagawa H; Takano Y; Ishida-Okawara A; Suzuki K; Maeda N; Koyama H
J Med Microbiol; 2006 Sep; 55(Pt 9):1291-1299. PubMed ID: 16914663
[TBL] [Abstract][Full Text] [Related]
79. Models for Inducing Experimental Cryptococcosis in Mice.
Castro-Lopez N; Wormley FL
Methods Mol Biol; 2024; 2775():29-46. PubMed ID: 38758309
[TBL] [Abstract][Full Text] [Related]
80. Persistence of infection in mice inoculated intranasally with Cryptococcus neoformans.
Anderson DA; Sagha HM
Mycopathologia; 1988 Dec; 104(3):163-9. PubMed ID: 3070384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
